None of us could have anticipated the COVID-19 pandemic, and due to the pause on screenings, millions of mammograms have been deferred.
Artificial Intelligence (AI) has arrived in radiology and is quickly moving from the lab to clinical use. A recent survey shows that healthcare executives are not only embracing the use of artificial intelligence, they’re making budgetary plans to bring the technology into their organizations.
We are honored to share the news that CureMetrix was selected by an esteemed panel of industry and clinical experts as the Best New Radiology Vendor for 2019 https://www.einpresswire.com/article/500004616/curemetrix-wins-best-new-radiology-vendor-of-the-year
Artificial intelligence (AI) in healthcare has evolved quickly, and today interest is surging. After its early days in R&D and testing, we’re now seeing the emergence of powerful FDA-cleared products with vast potential to reshape and enhance patient screening, diagnosis and treatment.